These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Massachusetts has the lowest uninsured rate among women – 7.9 times lower than in Texas, which has the highest rate.

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

Semaglutide reduced the risk of kidney disease worsening, renal failure ... CV death), and time to occurrence of all-cause death. “This approval for Ozempic allows us to more broadly address ...

analyzed data from more than 2 million people with diabetes who took GLP-1 receptor agonist medications like Ozempic and ...

How the Drugs Might Work Researchers don’t know how drugs like Ozempic might protect against neurodegenerative ... including heart and kidney disease. The same dynamic may be happening in the brain: ...